| 2025 | 2024 | 2023 | ||||
|---|---|---|---|---|---|---|
| Gross margin | 178,9 k € | +424.1% | 34,1 k € | +116.0% | 15,8 k € | |
| EBITDA | 176,5 k € | +441.8% | 32,6 k € | +109.0% | 15,6 k € | |
| Operating profit | 169,5 k € | +425.5% | 32,2 k € | +108.6% | 15,5 k € | |
| Profit/loss | 127,7 k € | +441.0% | 23,6 k € | +101.7% | 11,7 k € | |
| Equity | 165,9 k € | +333.3% | 38,3 k € | +160.5% | 14,7 k € | |
| Total assets | 176,0 k € | +248.8% | 50,5 k € | +125.7% | 22,4 k € | |
| Cash | 50,5 k € | — | 7,3 k € | |||
| Debts | 10,1 k € | -16.6% | 12,1 k € | +57.5% | 7,7 k € | |
Private limited company · Brugge · incorporated on 12/07/2023
Private limited company profitable and well capitalised. Cash position rising (+595.1%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
Rayos X is a Private limited company incorporated in 2023. Its main activity is: Specialist medical practice activities. Its registered office is in Brugge.